Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis
- PMID: 19361507
- DOI: 10.1053/j.gastro.2009.04.001
Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis
Abstract
Background & aims: Various commensal enteric and potentially pathogenic bacteria may be involved in the pathogenesis of inflammatory bowel diseases (IBD). We compared the risk of IBD between a cohort of patients with documented Salmonella or Campylobacter gastroenteritis and an age- and gender-matched control group from the same population in Denmark.
Methods: We identified 13,324 patients with Salmonella/Campylobacter gastroenteritis from laboratory registries in North Jutland and Aarhus counties, Denmark, from 1991 through 2003, and 26,648 unexposed controls from the same counties. Of these, 176 exposed patients with IBD before the infection, their 352 unexposed controls, and 80 unexposed individuals with IBD before the Salmonella/Campylobacter infection were excluded. The final study cohort of 13,148 exposed and 26,216 unexposed individuals were followed for up to 15 years (mean, 7.5 years).
Results: A first-time diagnosis of IBD was reported in 107 exposed (1.2%) and 73 unexposed individuals (0.5%). By age, gender, and comorbidity adjusted Cox proportional hazards regression analysis, the hazard ratio (95% confidence interval) for IBD was 2.9 (2.2-3.9) for the whole period and 1.9 (1.4-2.6) if the first year after the Salmonella/Campylobacter infection was excluded. The increased risk in exposed subjects was observed throughout the 15-year observation period. The increased risk was similar for Salmonella (n = 6463) and Campylobacter (n = 6685) and for a first-time diagnosis of Crohn's disease (n = 47) and ulcerative colitis (n = 133).
Conclusions: In our population-based cohort study with complete follow-up, an increased risk of IBD was demonstrated in individuals notified in laboratory registries with an episode of Salmonella/Campylobacter gastroenteritis.
Comment in
-
Infection, inflammation, and homeostasis in inflammatory bowel disease.Gastroenterology. 2009 Aug;137(2):415-8. doi: 10.1053/j.gastro.2009.06.019. Epub 2009 Jun 27. Gastroenterology. 2009. PMID: 19563834 No abstract available.
Similar articles
-
Increased risk of zoonotic Salmonella and Campylobacter gastroenteritis in patients with haematological malignancies: a population-based study.Ann Hematol. 2009 Aug;88(8):761-7. doi: 10.1007/s00277-008-0662-x. Epub 2008 Dec 16. Ann Hematol. 2009. PMID: 19083236
-
Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease.Gastroenterology. 2006 May;130(6):1588-94. doi: 10.1053/j.gastro.2006.02.004. Gastroenterology. 2006. PMID: 16697722
-
Salmonella or Campylobacter gastroenteritis prior to a cancer diagnosis does not aggravate the prognosis: a population-based follow-up study.APMIS. 2010 Feb;118(2):136-42. doi: 10.1111/j.1600-0463.2009.02571.x. APMIS. 2010. PMID: 20132177
-
Gastrointestinal infection as a trigger for inflammatory bowel disease.Curr Opin Gastroenterol. 2012 Jan;28(1):24-9. doi: 10.1097/MOG.0b013e32834c453e. Curr Opin Gastroenterol. 2012. PMID: 22080823 Review.
-
Genetic determinants of pediatric inflammatory bowel disease: is age of onset genetically determined?Dig Dis. 2009;27(3):236-9. doi: 10.1159/000228555. Epub 2009 Sep 24. Dig Dis. 2009. PMID: 19786746 Review.
Cited by
-
The Essential Role of Selenoproteins in the Resolution of Citrobacter rodentium-Induced Intestinal Inflammation.Front Nutr. 2020 Jul 8;7:96. doi: 10.3389/fnut.2020.00096. eCollection 2020. Front Nutr. 2020. PMID: 32775340 Free PMC article.
-
Consistent activation of the β-catenin pathway by Salmonella type-three secretion effector protein AvrA in chronically infected intestine.Am J Physiol Gastrointest Liver Physiol. 2012 Nov 15;303(10):G1113-25. doi: 10.1152/ajpgi.00453.2011. Epub 2012 Sep 13. Am J Physiol Gastrointest Liver Physiol. 2012. PMID: 22982337 Free PMC article.
-
Prophylactic Activity of Orally Administered FliD-Reactive Monoclonal SIgA Against Campylobacter Infection.Front Immunol. 2020 Jun 9;11:1011. doi: 10.3389/fimmu.2020.01011. eCollection 2020. Front Immunol. 2020. PMID: 32582158 Free PMC article.
-
Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel Disease.Am J Gastroenterol. 2018 Oct;113(10):1530-1539. doi: 10.1038/s41395-018-0211-8. Epub 2018 Aug 3. Am J Gastroenterol. 2018. PMID: 30072777 Free PMC article.
-
Autoantibodies and an immune-based rat model of inflammatory bowel disease.World J Gastroenterol. 2013 Nov 21;19(43):7569-76. doi: 10.3748/wjg.v19.i43.7569. World J Gastroenterol. 2013. PMID: 24282347 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical